<- Go Home
AddLife AB (publ)
AddLife AB (publ), together with its subsidiaries, provides instruments and equipment, consumables, and reagents primarily to medical care, research, colleges, and universities, as well as the food and pharmaceutical industries. The company operates in two segments, Labtech and Medtech. The Labtech segment offers products, solutions, and services in the areas of diagnostics, and biomedical research and laboratory analysis. It offers products and solutions, including analytical instruments, equipment, microscopes, consumables, and reagents, as well as software support and technical services; and in the areas of microbiology, clinical chemistry, coagulation, molecular biology, research, immunology, point-of-care testing, veterinary diagnostics, as well as in the food industry. This segment also provides training programs for its customers. The Medtech segment provides medical device products for surgery, orthopaedics, critical care, endoscopy, wound care, healthcare IT, ophthalmology, home adaptation, and technical aids, as well as surgical procedures, welfare technology, and assistive devices for the elderly and disabled. It operates in Sweden, the United Kingdom, Ireland, Spain, Denmark, Norway, Italy, Finland, Switzerland, Germany, Poland, Austria, rest of Europe, and internationally. AddLife AB (publ) was founded in 1906 and is based in Stockholm, Sweden.
Market Cap
SEK 19.6B
Volume
126.7K
Cash and Equivalents
SEK 394.0M
EBITDA
SEK 1.4B
Tax Rate Collected
N/A
Tax Rate Ratio
N/A
Gross Profit
SEK 4.0B
Profit Margin
38.43%
52 Week High
SEK 208.40
52 Week Low
SEK 130.20
Dividend
0.93%
Price / Book Value
3.45
Price / Earnings
32.97
Price / Tangible Book Value
-9.06
Enterprise Value
SEK 24.3B
Enterprise Value / EBITDA
14.91
Operating Income
SEK 867.0M
Return on Equity
10.94%
Return on Assets
4.17
Cash and Short Term Investments
SEK 394.0M
Debt
SEK 5.0B
Equity
SEK 5.7B
Revenue
SEK 10.5B
Unlevered FCF
SEK 910.9M
Sector
Life Sciences Tools and Services
Category
N/A